MUKKA NSE filing

Mukka Proteins Announces 16th AGM on September 10, 2026

The RealCase readLow impact Neutral

Mukka Proteins Limited will hold its 16th Annual General Meeting on September 10, 2026, at 3:00 PM IST. The meeting will be conducted via Video Conferencing with e-voting facilities available. Members are advised to update their contact details with DPs for receiving AGM notices and annual reports.

Why it matters

This is a standard procedural announcement for an upcoming AGM and does not involve any immediate financial or operational changes that would have a significant impact on the company.

The market read

The announcement is a routine corporate communication regarding the Annual General Meeting and does not contain any financial performance data or strategic decisions that would significantly impact the sentiment.

Mukka Proteins Limited has announced that its 16th Annual General Meeting (AGM) will be held on Thursday, September 10, 2026, at 03:00 p.m. (IST). The meeting will be conducted through Video Conferencing (VC) / Other Audio Visual Means (OA VM) in compliance with the Companies Act, 2013, and SEBI regulations.

Members will be provided with remote e-voting facilities prior to and during the AGM. Detailed instructions for e-voting and joining the AGM via VC/OA VM will be included in the Notice of the 16th AGM. The company is also advising members to update their email addresses with their Depository Participants (DPs) to receive communications, including the AGM Notice and Annual Report for FY 2025-26, via email. Members can also request hard/soft copies of these documents by writing to investors@mukkaproteins.com. The AGM Notice and Annual Report will also be available on the company's website and the websites of BSE and NSE.

The newspaper advertisements regarding the AGM were published on Friday, August 14, 2026, in Business Standard (English) and Vijaya Karnataka (Kannada).

Filing to action

What to do with a filing like this

Mukka Proteins Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Mukka Proteins Limited. Read the original for the full detail.

View original filing